Early carotid atherosclerosis in overweight non-diabetic individuals is associated with subclinical chronic inflammation independent of underlying insulin resistance

Hormone and Metabolic Research

Volumn 37, Issue 5, 2005, Pages 331-335

  Balletshofer, Bernd M ^a,b   Haap, M ^a   Rittig, K ^a   Stock, J ^a   Lehn Stefan, A ^a   Haring H U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atheriosclerosis; Body weight; C reactive protein; Cell adhesion molecules; Cholesterol; Glucose clamp technique; Glucose tolerance test; Insulin resistance; Tunica intima; Ultrasonography

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ADULT; AGE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; GENDER; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; INDUSTRIALIZATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CAROTID ARTERY DISEASES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY;

EID: 21244436010     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861479     Document Type: Article

References (28)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787
2. Balletshofer BM, Haring HU. Type 2-diabetes, insulin resistance and endothelial dysfunction. Hämostaseologie 2001; 21: 159-166
3. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784
4. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48: 1856-1862
5. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K et al. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003; 171: 303-309
6. Jarvisalo MJ, Harmoinen A, Hakanen M, Paakunainen U, Viikari J, Hartiala J et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arteriosclerosis Thrombosis and Vascular Biology 2002; 22: 1323-1328
7. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M et al. Cardiovascular risk factors and atherosclerosis in young males - ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 2003; 108: 1064-1069
8. Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994; 15: 781-785
9. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22
10. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
11. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996; 45: 947-953
12. Balletshofer BM, Rittig K, Stock J, Haring HU. Indicators of incipient atherosclerosis: Demonstration of endothelial dysfunction with high-resolution ultrasound. Ultraschall in der Medizin 2003; 24: 153-161
13. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991; 11: 565-577
14. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406
15. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28: 665-671
16. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-1415
17. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002; 51: 3069-3076
18. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima-media thickness in non-diabetic individuals. Diabetologia 1998; 41: 706-712
19. Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004; 24: 739-743
20. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126
21. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 8: 1211-1217
22. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267: E187-E202
23. Laight DW, Carrier MJ, Anggard EE. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 1999; 15: 274-282
24. Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22 Suppl 3: C25-C30
25. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658
26. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906
27. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202-206
28. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of vascular disease in metabolic syndrome X. J Diabetes Complications 2002; 16: 17-18